Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.48 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.48 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | AKT1 | P31749 | 1/20 | 0.41 |
| ▸ | AKT2 | P31751 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | METAP2 | P50579 | 1/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.38 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.38 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL150762 | 1.00 | GABRA1 (0.48) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| Bromide SCHEMBL28568919 | 0.98 | GABRA1 (0.47) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| Benzamide SCHEMBL28855712 | 0.82 | CYP2C19 (0.52) | RAB9ANPC1ALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL30950412 | 0.76 | — | — | |
| SCHEMBL29584431 | 0.76 | GABRG2 (0.51) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL12806833 | 0.72 | GABRA1 (0.54) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL151034 | 0.71 | GABRA1 (0.43) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL21938127 | 0.71 | GABRA1 (0.54) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL29516145 | 0.71 | GABRA1 (0.43) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL23888753 | 0.71 | KDM4E (0.58) | RAB9ANPC1ALDH1A1METAP2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608454-A1 | SELF-HYDROLYZING MALEIMIDES FOR BIOCONJUGATION | Eli Lilly and Company (US) | 2025-09-03 | — | — | EP | claimed |
| WO-2025136890-A1 | HYDROGEL NANOPARTICLES AS LABELING SCAFFOLD IN SEQUENCING | ILLUMINA, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| US-20250197933-A1 | HYDROGEL NANOPARTICLES AS LABELING SCAFFOLD IN SEQUENCING | ILLUMINA, INC. | 2025-06-19 | — | — | US | claimed |
| WO-2025049700-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID SEQUENCING | ILLUMINA, INC. (US) | 2025-03-06 | — | — | WO | claimed |
| US-20250075269-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID SEQUENCING | ILLUMINA, INC. | 2025-03-06 | — | — | US | claimed |
| WO-2024092219-A1 | SELF-HYDROLYZING MALEIMIDES FOR BIOCONJUGATION | ELI LILLY AND COMPANY (US) | 2024-05-02 | — | — | WO | claimed |
| EP-4196581-B1 | SEQUENTIAL ENCODING METHODS AND RELATED KITS | ENCODIA INC (US) | 2026-02-25 | — | — | EP | disclosed |
| EP-4127157-B1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | ENCODIA INC (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4684031-A1 | POINT OF CARE DIAGNOSTIC METHODS | GLIA Diagnostics Pty Ltd (AU) | 2026-01-28 | — | — | EP | disclosed |
| US-20260009068-A1 | METHODS FOR BARCODING MACROMOLECULES IN INDIVIDUAL CELLS | Encodia, Inc. (US) | 2026-01-08 | — | — | US | disclosed |
| US-12498378-B2 | Methods for spatial analysis of proteins and related kits | DF PEPTIDE ACQUISITION LLC | 2025-12-16 | — | — | US | disclosed |
| US-12474346-B2 | Methods and kits for multicycle encoding assay | DF PEPTIDE ACQUISITION LLC | 2025-11-18 | — | — | US | disclosed |
| EP-4646595-A1 | PEPTIDE SEQUENCER | Oregon Health & Science University (US) | 2025-11-12 | — | — | EP | disclosed |
| US-20220144885-A1 | CONJUGATION REAGENTS AND METHODS USING 1,2-CYCLOHEXANEDIONES | Encodia, Inc. (US) | 2022-05-12 | — | — | US | disclosed |
| WO-2022094148-A1 | CONJUGATION REAGENTS AND METHODS USING 1,2-CYCLOHEXANEDIONES | Encodia, Inc. (US) | 2022-05-05 | — | — | WO | disclosed |
| US-20220127754-A1 | METHODS AND COMPOSITIONS OF ACCELERATING REACTIONS FOR POLYPEPTIDE ANALYSIS AND RELATED USES | Encodia, Inc. (US) | 2022-04-28 | — | — | US | disclosed |
| US-20220106278-A1 | REAGENTS AND METHODS FOR TETRAZINE SYNTHESIS | UNIVERSITY OF DELAWARE (US) | 2022-04-07 | — | — | US | disclosed |
| WO-2022072560-A1 | POLYPEPTIDE TERMINAL BINDERS AND USES THEREOF | Encodia, Inc. (US) | 2022-04-07 | — | — | WO | disclosed |
| EP-3973299-A1 | METHODS AND RELATED KITS FOR SPATIAL ANALYSIS | Encodia, Inc. (US) | 2022-03-30 | — | — | EP | disclosed |
| EP-3963070-A1 | METHODS FOR PREPARING ANALYTES AND RELATED KITS | Encodia, Inc. (US) | 2022-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220144885-A1 | CONJUGATION REAGENTS AND METHODS USING 1,2-CYCLOHEXANEDIONES | TNNI3, CHD1, TNNT2 | GABRA1 4504/4885GABRG2 4809/4885GABRB3 4707/4885 |
| US-20260009068-A1 | METHODS FOR BARCODING MACROMOLECULES IN INDIVIDUAL CELLS | HNRNPAB, ACTB, SSBP1 | GABRA1 2763/4885GABRG2 2879/4885GABRB3 1512/4885 |
| US-20220106278-A1 | REAGENTS AND METHODS FOR TETRAZINE SYNTHESIS | TST, CYP4F8, CYP4Z1 | GABRA1 1608/4885GABRG2 1810/4885GABRB3 2048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.